Both in vitro and in vivo studies revealed that exosomes derived from oxaliplatin-resistant CRC cells transferred ciRS-122 into oxaliplatin-sensitive CRC cells, and subsequently the expression levels of ciRS-122 and PKM2 protein were upregulated in oxaliplatin-sensitive cells [123]. This evidence concerns the gene PKM and colorectal carcinoma.